Title:
ANTI-ANXIETY COMPOSITION
Document Type and Number:
WIPO Patent Application WO/2022/230489
Kind Code:
A1
Abstract:
The purpose of the present invention is to provide an anti-anxiety composition for humans and a method for preventing or improving anxiety symptoms. The present invention pertains to an anti-anxiety composition for humans that comprises L-ergothioneine or a salt thereof as an active ingredient.
More Like This:
| WO/2000/025774 | BENZAMIDE POTASSIUM CHANNEL INHIBITORS |
| JP2022540585 | cannabinoid derivatives |
| JP2001506657 | INDUSTRIAL APPLICABILITY [Invention title] Indane-or dihydroindole derivative |
Inventors:
KATSUBE MAKOTO (JP)
WATANABE HIROSHI (JP)
MURAYAMA NORIHITO (JP)
WATANABE HIROSHI (JP)
MURAYAMA NORIHITO (JP)
Application Number:
PCT/JP2022/014237
Publication Date:
November 03, 2022
Filing Date:
March 25, 2022
Export Citation:
Assignee:
SUNTORY HOLDINGS LTD (JP)
International Classes:
A61P25/22; A23L33/175; A61K31/4172; A61K36/07; A61P43/00
Foreign References:
| JP2014193844A | 2014-10-09 | |||
| JP2019180364A | 2019-10-24 | |||
| JP2014193844A | 2014-10-09 |
Other References:
TAKEDA, YUKA ET AL.: "Effect of ergothioneine, and antioxidant constituent of Tamogi-take on learning ability and neuronal maturation", ABSTRACTS OF THE 11TH ACADEMIC MEETING OF GENE NUTRITION STUDY GROUP, LS CORPORATION, TOKOY, JP, Tokoy, JP, XP009540895, Retrieved from the Internet
Attorney, Agent or Firm:
WISEPLUS IP FIRM (JP)
Download PDF: